Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CytoDyn Inc
CYDY
Healthcare
Biotechnology
CytoDyn Inc. is a clinical-stage oncology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. It has studied leronlimab in multiple therapeutic areas, including infectious...
disease, oncology, and autoimmune conditions. The Company has conducted clinical trials of leronlimab as a viral entry inhibitor for human immunodeficiency virus (HIV), believed to competitively bind to the N-terminus and second extracellular loop of the CCR5 receptor. For immunology, the CCR5 receptor is believed to be implicated in immune-mediated illnesses, such as metabolic dysfunction-associated steatohepatitis. It has a joint development agreement with a third-party generative artificial intelligence (AI) drug discovery and development company to develop one or more longer-acting molecules.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CYDY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(564)
•••
Pandora
X
Comment by
Pandora
on May 16, 2025 6:38pm
RE:RE:RE:RE:.
CYDY was showing signs of getting new life and then they presented a "poster" presented at the European Society for Medical Oncology’s (“ESMO”) Breast Cancer meeting on May 14-17, 2025, in
...more
(564)
•••
Pandora
X
Post by
Pandora
on Aug 22, 2024 7:32pm
Patent Application
I find this very strange for a company that is struggling for positive news. I contacted the company about it and they said "we have it under control" or words to that effect. What it is is
...more
(564)
•••
Pandora
X
Post by
Pandora
on Jul 09, 2024 10:48am
Finally, a Court Settlement!
CytoDyn Inc. Terms of the settlement include $12,000,000 cash payment to CytoDyn and elimination of $14,000,000 accounts payable liability from the Company’s balance sheet VANCOUVER, Washington
...more
(564)
•••
Pandora
X
Comment by
Pandora
on May 31, 2024 3:25pm
RE:RE:RE:.
Don't know what they said in their conference call yesterday but as usual it sure spooked the audience. Completely whacked today.
(564)
•••
Pandora
X
Comment by
Pandora
on May 17, 2024 9:41pm
RE:RE:RE:.
Presumably nobody on here has access to the Yahoo board. Oh well! Funny they have a virtual approval on their Patent - all they have to do is pay $480 but for some reason they do not appear to be
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Mar 21, 2024 12:57am
RE:RE:.
If anybody reading this patent stuff has access to the Yahoo board it might be helpful to copy and post over there.
(564)
•••
Pandora
X
Comment by
Pandora
on Mar 21, 2024 12:53am
RE:.
CYDY has a new patent that is virtually approved -- that is, it has been given a Notice of Allowance by the USPTO which means they have to pay a fee and then wait for the approval of a new
...more
(667)
•••
My19sixyNineZ
X
Post by
My19sixyNineZ
on Mar 05, 2024 9:39am
.
Imagine finding a new drug candidate as a shareholder & not yet knowing how it will perform in even 1 dosing. Unknown safety, cost, etc...etc.. It then blows the doors off many SOC's. Holy
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Mar 04, 2024 11:43pm
RE:CytoDyn Announces FDA Has Lifted Clinical Hold
If nothing else the daily volume has taken a jump. Share price not so much of a jump, more of a stumble, in the right direction.
(667)
•••
My19sixyNineZ
X
Post by
My19sixyNineZ
on Mar 04, 2024 11:40pm
Thank you Dr. J & Mgt, BOD & Advisors !!
Trying to give thanks @ Yazooo & keeps deleting. They've tossed tha baby out with the bath water AND did a remodeling. I could laundry list the good
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Dec 29, 2022 4:09pm
RE:RE:WOW WTF?
Seems like the market was right. Another nothing burger. Offhand I would have to give these guys an 'F' for rating their ability to communicate. We get an announcement about once a month and
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Dec 29, 2022 10:08am
RE:WOW WTF?
By the looks of price and volume it seems like expectations for today's update are a "zero". I hope it is a little bit better than that, or this is a write off, which many people have
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Dec 23, 2022 1:47am
RE:Patent movement
The USPTO has been busy - there is also some movement on a second patent application. I have read the Examiners document but don't understand it and bottom line it is being turned back to the
...more
(564)
•••
Pandora
X
Post by
Pandora
on Dec 23, 2022 1:04am
Patent movement
Finally a little movement on a cancer fighting patent through the USPTO. The Company is in a drastic downfall at the moment so not sure this will help at all and at this stage it has just been passed
...more
(564)
•••
Pandora
X
Comment by
Pandora
on Nov 23, 2022 3:19pm
RE:WOW WTF?
Used to watch this stock on the Yahoo board but they redesigned that board and it is a total mess. I can't even figure out how to get into it. It says "sign up" or "log in" to
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine